$EDXC
Endexx Corp Stock $edxc

$edxc Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000149315223005794 Filed on February 22, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q3
Revenue	$2.834M	$320.4K	$330.2K
YoY Change	1012.87%	16.67%	40.84%
Cost Of Revenue	$2.440M	$72.80K	$225.9K
YoY Change	2990.41%	-68.41%	-266.62%
Gross Profit	$394.2K	$242.3K	$104.2K
YoY Change	124.32%	448.61%	-71.83%
Gross Profit Margin	13.91%	75.64%	31.57%
Selling, General & Admin	$807.4K	$715.2K	$824.4K
YoY Change	10.6%	-50.08%	-49.27%
% of Gross Profit	204.81%	295.14%	790.96%
Research & Development	$1.490K	$3.062K	$5.390K
YoY Change	-91.02%	30.3%	72.76%
% of Gross Profit	0.38%	1.26%	5.17%
Depreciation & Amortization	$2.360K	$2.570K	$3.770K
YoY Change	-53.73%	-49.61%	-26.08%
% of Gross Profit	0.6%	1.06%	3.62%
Operating Expenses	$811.2K	$720.8K	$833.6K
YoY Change	7.92%	-49.95%	-48.96%
Operating Profit	-$417.0K	-$478.5K	-$729.4K
YoY Change	-27.6%	-65.72%	-42.26%
Interest Expense	-$1.109M	$283.0K	$12.17M
YoY Change	-52.03%	-183.79%	-2758.62%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$768.4K	$66.35K
YoY Change		244.16%
Pretax Income	-$1.526M	-$1.247M	$11.51M
YoY Change	-45.1%	-24.3%	-706.28%
Income Tax
% Of Pretax Income
Net Earnings	-$1.526M	-$1.247M	$11.51M
YoY Change	-45.1%	-24.3%	-706.28%
Net Earnings / Revenue	-53.83%	-389.2%	3485.9%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.02
COMMON SHARES
Basic Shares Outstanding	506.4M shares	502.7M shares	523.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$155.0K	$5.640K	$365.2K
YoY Change	483.18%	-97.06%	1086.09%
Cash & Equivalents		$5.642K	$365.2K
Short-Term Investments
Other Short-Term Assets	$1.195M	$264.6K	$279.6K
YoY Change	4549.69%	929.42%	571.21%
Inventory	$645.0K	$730.5K	$777.9K
Prepaid Expenses		$264.6K	$279.6K
Receivables	$790.6K	$115.0K	$256.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.786M	$1.116M	$1.679M
YoY Change	162.16%	-7.1%	62.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$73.11K	$25.44K	$28.01K
YoY Change	-83.36%	-89.82%	-93.77%
Goodwill			$9.807M
YoY Change
Intangibles
YoY Change
Long-Term Investments	$420.00	$2.000M	$2.000M
YoY Change	0.0%	20065.52%	20065.52%
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$9.897M	$3.542M	$3.545M
YoY Change	1301.6%	391.46%	388.36%
TOTAL ASSETS
Total Short-Term Assets	$2.786M	$1.116M	$1.679M
Total Long-Term Assets	$9.897M	$3.542M	$3.545M
Total Assets	$12.68M	$4.658M	$5.223M
YoY Change	617.08%	142.38%	196.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.087M	$2.249M	$2.253M
YoY Change	100.45%	90.99%	120.81%
Accrued Expenses	$1.878M	$19.76K	$19.76K
YoY Change	-26.58%	-99.13%	-54.55%
Deferred Revenue		$15.18K	$15.18K
YoY Change			-58.64%
Short-Term Debt	$1.000M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.348M	$7.200M	$6.571M
YoY Change	-16.52%	-6.3%	-1.24%
Total Short-Term Liabilities	$20.36M	$10.73M	$10.01M
YoY Change	34.53%	-14.23%	-12.93%
LONG-TERM LIABILITIES
Long-Term Debt	$4.294M	$3.160M	$3.366M
YoY Change	1630.15%	1173.17%	1256.03%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$4.294M	$3.160M	$3.366M
YoY Change	1630.15%	1173.17%	1256.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.36M	$10.73M	$10.01M
Total Long-Term Liabilities	$4.294M	$3.160M	$3.366M
Total Liabilities	$23.84M	$13.89M	$13.38M
YoY Change	54.94%	8.87%	13.89%
SHAREHOLDERS EQUITY
Retained Earnings		-$44.89M	-$43.64M
YoY Change			10.45%
Common Stock		$50.41K	$50.14K
YoY Change			3.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.16M	-$9.233M	-$8.155M
YoY Change
Total Liabilities & Shareholders Equity	$12.68M	$4.658M	$5.223M
YoY Change	617.08%	142.38%	196.8%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.526M	-$1.247M	$11.51M
YoY Change	-45.1%	-24.3%	-706.28%
Depreciation, Depletion And Amortization	$2.360K	$2.570K	$3.770K
YoY Change	-53.73%	-49.61%	-26.08%
Cash From Operating Activities	$503.7K	-$358.8K	-$235.9K
YoY Change	-388.31%	-62.07%	-59.06%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$1.500M
YoY Change	-100.0%
Cash From Investing Activities	$0.00		-$1.500M
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-355.3K	-$731.00	2.095M
YoY Change		-100.07%	264.26%
NET CHANGE
Cash From Operating Activities	503.7K	-$358.8K	-235.9K
Cash From Investing Activities	0.000		-1.500M
Cash From Financing Activities	-355.3K	-$731.00	2.095M
Net Change In Cash	148.4K	-$359.5K	358.6K
YoY Change	-189.81%		-30234.45%
FREE CASH FLOW
Cash From Operating Activities	$503.7K	-$358.8K	-$235.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001109486
CY2022Q4	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2022Q4	EDXC	Default Penalties DefaultPenalties		usd
CY2021Q4	EDXC	Default Penalties DefaultPenalties		usd
CY2022Q4	EDXC	Gain From Settlement Of Derivative Liability GainFromSettlementOfDerivativeLiability		usd
CY2021Q4	EDXC	Gain From Settlement Of Derivative Liability GainFromSettlementOfDerivativeLiability		usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021Q4	EDXC	Shares Issued For Settlement SharesIssuedForSettlement		usd
CY2022Q4	EDXC	Shares Issued For Financing Costs SharesIssuedForFinancingCosts		usd
CY2022Q4	EDXC	Warrants Issued For Financing Costs WarrantsIssuedForFinancingCosts		usd
CY2022Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2022Q4	EDXC	Gain From Settlement Of Liabilities GainFromSettlementOfLiabilities		usd
CY2022Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0353162
CY2022Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	38246 North Hazelwood Circle
CY2022Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	Cave Creek
CY2022Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2022Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85331
CY2022Q4	dei	City Area Code CityAreaCode	(480)
CY2022Q4	EDXC	Gain From Settlement Of Derivative Liability GainFromSettlementOfDerivativeLiability		usd
CY2021Q4	EDXC	Gain From Settlement Of Derivative Liability GainFromSettlementOfDerivativeLiability		usd
CY2022Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021Q4	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022Q4	EDXC	Financing Costs FinancingCosts		usd
CY2022Q4	EDXC	Default Penalty DefaultPenalty		usd
CY2021Q4	EDXC	Default Penalty DefaultPenalty		usd
CY2022Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2022Q4	EDXC	Increase Decreasein Accrued Interest Related Party IncreaseDecreaseinAccruedInterestRelatedParty		usd
CY2021Q4	EDXC	Increase Decreasein Accrued Interest Related Party IncreaseDecreaseinAccruedInterestRelatedParty		usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2021Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	EDXC	Debt Discount At Origination DebtDiscountAtOrigination		usd
CY2022Q4	dei	Document Type DocumentType	10-Q
CY2022Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q4	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	dei	Local Phone Number LocalPhoneNumber	595-6900
CY2022Q4	dei	Entity File Number EntityFileNumber	000-30233
CY2022Q4	dei	Entity Registrant Name EntityRegistrantName	Endexx Corporation
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	2134	usd
CY2022Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	506357952	shares
CY2022Q4	us-gaap	Cash Cash	5642	usd
CY2022Q3	us-gaap	Cash Cash	365162	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58257	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58257	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	115014	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	256096	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	1076716	usd
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	1071469	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	730532	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	777911	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	264560	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	279560	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1115748	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1678729	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	420	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	420	usd
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	2000000	usd
CY2022Q3	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	2000000	usd
CY2022Q4	EDXC	Note Receivable Noncurrent NoteReceivableNoncurrent	1500000	usd
CY2022Q3	EDXC	Note Receivable Noncurrent NoteReceivableNoncurrent	1500000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79610	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77044	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25439	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28005	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16250	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16250	usd
CY2022Q4	us-gaap	Assets Assets	4657857	usd
CY2022Q3	us-gaap	Assets Assets	5223404	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2249382	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2253250	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15182	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15182	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19756	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19756	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	317703	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	237703	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	929186	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	915230	usd
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	492786146	shares
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	4291	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5978942	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	5771861	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1220817	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-9987141	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	799575	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10730968	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	209893	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	254639	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	10012557	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	3160000	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	3365655	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13890968	usd
CY2022Q3	us-gaap	Liabilities Liabilities	13378212	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	504095364	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	504095364	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	501376264	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	501376264	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	50410	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	50138	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35605486	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35437174	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44889677	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43642790	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9233111	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8154808	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4657857	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5223404	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	320369	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	274591	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	72799	usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	230423	usd
CY2022Q4	EDXC	Inventory Impairment InventoryImpairment	5247	usd
CY2021Q4	EDXC	Inventory Impairment InventoryImpairment	27913	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	242323	usd
CY2021Q4	us-gaap	Gross Profit GrossProfit	16255	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2566	usd
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5100	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	93945	usd
CY2021Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	323648	usd
CY2022Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	82283	usd
CY2021Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	168086	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	329068	usd
CY2021Q4	us-gaap	Professional Fees ProfessionalFees	686373	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3062	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2351	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-478494	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1423942	usd
CY2021Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	427709	usd
CY2022Q4	EDXC	Financing Costs And Discount Amortization FinancingCostsAndDiscountAmortization	423399	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	720817	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	1440197	usd
CY2021Q4	EDXC	Financing Costs And Discount Amortization FinancingCostsAndDiscountAmortization	523196	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	282994	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	242254	usd
CY2021Q4	EDXC	Gain On Settlement Of Liabilities GainOnSettlementOfLiabilities	114478	usd
CY2022Q4	EDXC	Gain On Settlement Of Liabilities GainOnSettlementOfLiabilities	-62000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-768393	usd
CY2021Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-223263	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1246887	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-1647205	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	360906	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	502735814	shares
CY2021Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	135813	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-1647205	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-10837627	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8154808	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	106584	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	62000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1246887	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9233111	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1246887	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-1647205	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	106584	usd
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	300000	usd
CY2022Q4	EDXC	Shares Issued For Settlement SharesIssuedForSettlement	62000	usd
CY2021Q4	EDXC	Shares Issued For Financing Costs SharesIssuedForFinancingCosts	135813	usd
CY2021Q4	EDXC	Warrants Issued For Financing Costs WarrantsIssuedForFinancingCosts	360906	usd
CY2022Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2566	usd
CY2021Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5100	usd
CY2022Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	423399	usd
CY2021Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	26330	usd
CY2021Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	427709	usd
CY2021Q4	EDXC	Gain From Settlement Of Liabilities GainFromSettlementOfLiabilities	114478	usd
CY2022Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5247	usd
CY2021Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27913	usd
CY2021Q4	EDXC	Financing Costs FinancingCosts	147	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-141082	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33459	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-42132	usd
CY2021Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6394	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-15000	usd
CY2021Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-15952	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3868	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	157262	usd
CY2021Q4	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21523	usd
CY2021Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-26760	usd
CY2022Q4	EDXC	Increase Decrease In Accrued Interest IncreaseDecreaseInAccruedInterest	80000	usd
CY2021Q4	EDXC	Increase Decrease In Accrued Interest IncreaseDecreaseInAccruedInterest	218192	usd
CY2022Q4	EDXC	Increase Decrease In Payroll And Taxes Payable Primarily Related Party IncreaseDecreaseInPayrollAndTaxesPayablePrimarilyRelatedParty	13956	usd
CY2021Q4	EDXC	Increase Decrease In Payroll And Taxes Payable Primarily Related Party IncreaseDecreaseInPayrollAndTaxesPayablePrimarilyRelatedParty	84002	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-358789	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-945911	usd
CY2021Q4	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	999853	usd
CY2021Q4	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	116980	usd
CY2022Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	731	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-731	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1116833	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-359520	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	170922	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	365162	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20867	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5642	usd
CY2021Q4	us-gaap	Interest Paid Net InterestPaidNet	24062	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	191789	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	202994	usd
CY2021Q4	EDXC	Debt Discount At Origination DebtDiscountAtOrigination	111111	usd
CY2022Q4	EDXC	Working Capital Deficit WorkingCapitalDeficit	-25615220	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44889677	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1246887	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-358789	usd
CY2022Q4	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_z3ZET1SJZKQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_z0rH1JHhJ5D">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statement preparation requires that management make estimates and assumptions which affect the reporting of assets and liabilities and the related disclosure of contingent assets and liabilities in order to report these financial statements in conformity with GAAP. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58257	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58257	usd
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	264560	usd
CY2022Q3	us-gaap	Prepaid Advertising PrepaidAdvertising	279560	usd
CY2022Q4	EDXC	Schedule Of Property And Equipment Useful Lives ScheduleOfPropertyAndEquipmentUsefulLives	<p id="xdx_892_ecustom--ScheduleOfPropertyAndEquipmentUsefulLives_zEjQZxwe8ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation is computed on the straight-line method net of salvage value with useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zhHIvc7yb7nk" style="display: none">Schedule of Property and Equipment Useful Lives</span></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 30%"> </td> <td style="text-align: left; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer</span> equipment and software</td> <td style="text-align: right; width: 14%"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_c20221001__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zN06tR19LZc1" title="Useful lives property and equipment">5 years</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business</span> equipment and fixtures </td> <td style="text-align: right"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dt_c20221001__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--BusinessEquipmentandFixturesMember_zXZjmWzmAAsb" title="Useful lives property and equipment">7 years</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property</span> and buildings </td> <td style="text-align: right"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dt_c20221001__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PropertyandBuildingsMember_zEaqBbdXWKmj" title="Useful lives property and equipment">39 years</span></td></tr> </table>
CY2022Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3062	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2351	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	93945	usd
CY2021Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	323648	usd
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	201844703	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	201844703	shares
CY2022Q4	EDXC	Percentage For Beneficial Ownership Limitation Cap PercentageForBeneficialOwnershipLimitationCap	0.0499	pure
CY2021Q3	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedaverageExercisePrice	0.03
CY2022	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Outstanding Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeOutstandingEnding	P4Y10M24D
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4291	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	241815	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	249042	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1394247	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1427017	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	75000	usd
CY2022Q3	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	77135	usd
CY2022Q4	EDXC	Inventory Apparel InventoryApparel	96186	usd
CY2022Q3	EDXC	Inventory Apparel InventoryApparel	96186	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	1076716	usd
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	1071469	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	730532	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	777911	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105049	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105049	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79610	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	77044	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25439	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28005	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	9141076	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2134	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	9141807	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	9141807	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4291	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	88918645	shares
CY2022Q4	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedaverageExercisePrice	0.03
CY2022Q4	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Outstanding Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeOutstandingEnding	P4Y8M12D
CY2022Q4	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Execisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExecisableNumber	88918645	shares
CY2022Q4	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weightedaverage Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedaverageExercisePrice	0.03
CY2022Q4	EDXC	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weightedaverage Remaining Contractual Life Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedaverageRemainingContractualLifeExercisable	P4Y8M12D
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	128105	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	128105	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	801081	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	787125	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	929186	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	915230	usd
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one vote per share
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	504095364	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	501376264	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	88918645	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22500000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22500000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.01
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y8M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22500000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.01
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y8M12D
CY2019Q1	us-gaap	Collaborative Arrangement Rights And Obligations CollaborativeArrangementRightsAndObligations	we entered into an agreement with a third party to represent our products to customers, the term of the agreement is for four (4) years from the date of the contract, January 28, 2023, and has automatic four-year renewal clauses. We agreed to pay a commission of nineteen percent (19%), composed of ten percent (10%) for commission, two percent (2%) for override, and seven percent (7%) for expenses of managing and advertising the account. Within thirty (30) days of the end of the calendar year, we agreed to pay the representative a bonus for certain sales milestones if two percent (2%) of the net receipts, payable in shares of our restricted common stock
CY2022Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2000000	usd
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	2000000	usd
CY2022Q4	EDXC	Ownership Limitation Description OwnershipLimitationDescription	The Self-financing Note is subject to an “ownership limitation” such that the Seller cannot request that it be issued shares of our Common Stock as payment if such issuance would result in the Seller holding more than 4.99% of the then-issued and outstanding shares of our Common Stock (a “Conversion or Exercise Blocker”

Files In Submission

Name	View Source	Status
0001493152-23-005794-index-headers.html	Edgar Link	pending
0001493152-23-005794-index.html	Edgar Link	pending
0001493152-23-005794.txt	Edgar Link	pending
0001493152-23-005794-xbrl.zip	Edgar Link	pending
edxc-20221231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
edxc-20221231_cal.xml	Edgar Link	unprocessable
edxc-20221231_def.xml	Edgar Link	unprocessable
edxc-20221231_lab.xml	Edgar Link	unprocessable
edxc-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EDXC
Endexx Corp Stock $edxc

2023 Q1 Form 10-Q Financial Statement

#000149315223005794 Filed on February 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EDXC Endexx Corp Stock $edxc

2023 Q1 Form 10-Q Financial Statement

#000149315223005794 Filed on February 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EDXC
Endexx Corp Stock $edxc